“U.S. President Donald Trump signed an executive order on Wednesday to streamline federal regulation governing commercial rocket launches, a move that could benefit Elon Musk’s SpaceX and other private space ventures.
Trump’s order, among other things, directs the U.S. transportation secretary to eliminate or expedite environmental reviews for launch licenses administered by the Federal Aviation Administration, the White House said in a statement.”
From CNBC.
US Food and Drug Administration | Health & Medical Care
“The U.S. Food and Drug Administration today approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults. Orzeyful is the first medicine approved for narcolepsy type 1 as a complete disorder — addressing the full range of symptoms that define the condition — and the first to work by directly targeting the loss of orexin signaling that causes the disease.”
“California-based delivery platform DoorDash has launched its own drone delivery business after securing regulatory approval to operate commercial drone services in the United States.
The company has received Federal Aviation Administration (FAA) Part 135 air carrier certification, allowing it to launch DoorDash Air, an in-house drone programme developed by its robotics division, DoorDash Labs. Alongside operating the service, DoorDash is also developing its own aircraft for local deliveries.
The approval makes DoorDash one of only a handful of drone operators in the US authorised to run commercial delivery services under its own certificate.”
From Zag Daily.
“Ecuador and Canada signed a free trade agreement on Friday, Ecuador's government said, adding the deal will allow 99.6% of its exportable goods to enter Canada duty-free once it takes effect.”
From Reuters.
US Food and Drug Administration | Health Systems
“The U.S. Food and Drug Administration today licensed Ezplaz Freeze Dried Plasma (FDP), making it the first freeze-dried plasma product licensed for use in the United States. Ezplaz is intended for transfusion in adult patients who need plasma and for whom other plasma products are not available…
Unlike conventional plasma products that must be stored frozen and thawed before use, Ezplaz can be stored at room temperature, is stable after exposure to temperature fluctuations and is rapidly reconstituted. It is packaged in a plastic bag rather than a glass bottle, reducing the risk of breakage during handling and transport. FDA expects that these features will make the use of Ezplaz compatible with austere environments, potentially including combat zones, remote areas, and disaster response settings.”
